NKTR Stock Summary and Trading Ideas (Nektar Therapeutics | NASDAQ:NKTR)

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Nektar Therapeutics trades on the NASDAQ stock market under the symbol NKTR.

As of April 23, 2024, NKTR stock price climbed to $1.42 with 1,078,422 million shares trading.

NKTR has a beta of 1.33, meaning it tends to be more sensitive to market movements. NKTR has a correlation of 0.03 to the broad based SPY ETF.

NKTR has a market cap of $270.89 million. This is considered a Small Cap stock.

Last quarter Nektar Therapeutics reported $24 million in Revenue and -$.22 earnings per share. This beat revenue expectation by $6 million and missed earnings estimates by -$.01.

In the last 3 years, NKTR stock traded as high as $20.66 and as low as $.41.

The top ETF exchange traded funds that NKTR belongs to (by Net Assets): VTI, VXF, SCHA, PRFZ, VHT.

NKTR has outperformed the market in the last year with a price return of +63.2% while the SPY ETF gained +24.3%. NKTR has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +178.4% and +8.4%, respectively, while the SPY returned +4.9% and -2.5%, respectively.

NKTR support price is $1.26 and resistance is $1.47 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NKTR stock will trade within this expected range on the day.